DI002

WHOPAR

Part 1

Part 2a

Part 2b

Part 3

Part 4

Part 5

Part 6

Part 7

Part 8

Product name

Zinc (as sulfate monohydrate)

Dosage

20mg - Dispersible tablets

Laboratory

Laboratoires Pharmaceutiques Rodael

France

Part 1 - Abstract
Part 2a - All accepted presentations
Part 2b - Visual appearance of the product
Part 3 - Product Information Leaflet
Part 4 - Summary of Product Characteristics
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

Samples of the artworks of the SPC/PIL/labelling have not been submitted. Therefore, control of compliance with WHOPAR guidelines (contents and format) has not been possible.

Overview of WHO Public Assessment Report (WHOPAR)